Qiagen N.V. (QGEN)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 49.91 |
| Open | 49.67 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's range | 49.19 - 49.75 |
| 52-week range | 40.38 - 51.30 |
| Volume | |
| Avg. volume | 796,841 |
| Market cap | 11.226B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | 24.77 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
QIAGEN Launches EZ2 Connect MDx Platform for Automated Sample Processing in Diagnostic Labs
VENLO, The Netherlands, January 17, 2023--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of EZ2 Connect MDx for use in diagnostic laboratories, making the IVD platform for automated sample processing available for widescale use 18 months after being made available for research.
- Business Wire
QIAGEN N.V. to Release Results for Q4 and Full-Year Results 2022 and Hold Webcast
VENLO, Netherlands, January 17, 2023--QIAGEN N.V. to release results for Q4 and Full-Year results 2022 and hold webcast
- Business Wire
QIAGEN Completes Acquisition of Verogen, Strengthening Leadership in Human ID / Forensics With NGS Technologies
VENLO, The Netherlands & SAN DIEGO, January 09, 2023--QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) today announced it has completed the acquisition of Verogen, a leader in the use of next-generation sequencing (NGS) technologies to drive the future of human identification (HID) and forensic investigation.
© 2023 Yahoo. All rights reserved.
